Inferra AI / Company / CI
Cigna
CI · Health Care
Last earnings Sep 30, 2026 · Next earnings Nov 5, 2026
Key results
Consolidated Adjusted revenuequarter
$280 billion
Consolidated Adjusted Revenues of ~$280 billion Consolidated Adjusted EPS of at least $30.45 Evernorth Health Services pre-tax adjusted income from operations of at least $6.90 billion Cigna Healthcare pre-tax adjusted income from operations of at least $4.55 billion Medical care ratio of 83.7% to 84.7% The Cigna Group
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
Consolidated EPSquarter
83.7%
Consolidated Adjusted Revenues of ~$280 billion Consolidated Adjusted EPS of at least $30.45 Evernorth Health Services pre-tax adjusted income from operations of at least $6.90 billion Cigna Healthcare pre-tax adjusted income from operations of at least $4.55 billion Medical care ratio of 83.7% to 84.7% The Cigna Group
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
AI analysis
Latest earnings event · reported Sep 30, 2026
Based on: Earnings release + parent 8-K — transcript not held
The quarter in charts
Guidance ladder — revenue
Delivered vs the company's guided range
EX-99 · Sep 30, 2026 Guide as stated by the company; range and midpoint computed from the stated figure.
Headline figures
| Metric | Latest earnings event | Prior qtr | Year ago |
|---|---|---|---|
| Consolidated Adjusted revenue | $280 billion | — | — |
| Consolidated EPS | 83.7% | — | — |
Guidance · company-stated
Direction: Reiterated
“Reaffirms 2026 guidance and provides 2030 financial targets The Cigna Group reaffirms its 2026 financial guidance: Consolidated Adjusted Revenues of ~$280 billion Consolidated Adjusted EPS of at least $30.”
Classified from the release's primary full-year outlook statement.
Capital allocation
The Cigna Group s outlook includes the potential effects of expected future share repurchases and anticipated 2026 dividends.
The Cigna Group currently intends to pay regular quarterly dividends, with future declarations subject to approval by its Board of Directors and the Board s determination that the declaration of dividends remains in the best interests of The Cigna Group and its shareholders.
What changed vs last quarter
- Guide midpoint vs latest-quarter revenue 0.0% computed from stated figures
Event summary
Cigna — Earnings release (2026-09-30)
Based on: Earnings release + parent 8-K — transcript not held
Guidance & outlook
Direction: Reiterated
Revenue: “Reaffirms 2026 guidance and provides 2030 financial targets The Cigna Group reaffirms its 2026 financial guidance: Consolidated Adjusted Revenues of ~$280 billion Consolidated Adjusted EPS of at least $30.”
Revenue — Reiterated (“Reaffirms”)
“Reaffirms 2026 guidance and provides 2030 financial targets The Cigna Group reaffirms its 2026 financial guidance: Consolidated Adjusted Revenues of ~$280 billion Consolidated Adjusted EPS of at least $30.”
Classified from the release's primary full-year outlook statement.
Capital allocation
The Cigna Group s outlook includes the potential effects of expected future share repurchases and anticipated 2026 dividends.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
The Cigna Group currently intends to pay regular quarterly dividends, with future declarations subject to approval by its Board of Directors and the Board s determination that the declaration of dividends remains in the best interests of The Cigna Group and its shareholders.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
The decision of whether to pay future dividends and the amount of any such dividends will be based on The Cigna Group s financial position, results of operations, cash flows, capital requirements, the requirements of applicable law and any other factors the Board of Directors may deem relevant.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
The share repurchase program may be affected through open market purchases in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, including through Rule 10b5-1 trading plans, or privately negotiated transactions.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
Strategy & priorities
30, 2026 Today, at its Investor Day, The Cigna Group (NYSE: CI) will outline its strategy to improve affordability and personalization across the health care continuum.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
Introduces Lead to One Vision to Drive Durable Growth The Cigna Group is focused on transforming health care by improving affordability and delivering personalization for all customers across the care continuum.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
Lead to One is delivered through the strategic growth framework leaders will outline today: Deliver core growth : Build on the strong foundation of a deliberately shaped portfolio including Cigna Healthcare and Evernorth s Specialty & Care Services and Pharmacy Benefit Services to drive growth.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
This deliberately built foundation is aligned to attractive, growing segments of health care where the Company possesses meaningful scale, differentiated capabilities, and opportunities for continued expansion.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
The program will focus on strengthening the services and support systems that help patients start, stay on and benefit from treatment, including care navigation, education, peer support, mental health resources and assistance with essential social needs.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
Risks & headwinds
We relentlessly challenge ourselves to partner and innovate solutions for better health.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
Forward-looking statements are based on The Cigna Group s current expectations and projections about future trends, events and uncertainties.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
Forward-looking statements are subject to risks and uncertainties, both known and unknown, that could cause actual results to differ materially from those expressed or implied in forward-looking statements.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
You should not place undue reliance on forward-looking statements, which speak only as of the date they are made, are not guarantees of future performance or results, and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify.
SEC original ↗Cigna — Earnings release (8-K exhibit)EX-99Sep 30, 2026
Competitors
Competitors & peers
Named in the company’s own filings
Filings
61 documents- Q3 2026
- 8-KCI
Oct 9, 2026
- Q2 2026
- 8-KCI
Sep 30, 2026
- 10-QCI
Jul 30, 2026
- 8-KCI
Jul 30, 2026
- Q1 2026
- 8-KCI
May 13, 2026
- 10-QCI
Apr 30, 2026
- 8-KCI
Apr 30, 2026
- 8-KCI
Apr 27, 2026
- Q4 2025
- 8-KCI
Mar 3, 2026
- 8-KCI
Feb 27, 2026
- 10-KCI
Feb 26, 2026
- 8-KCI
Feb 5, 2026
- Q3 2025
- 8-KCI
Nov 18, 2025
- 10-QCI
Oct 30, 2025
- 8-KCI
Oct 30, 2025
- 8-KCI
Oct 20, 2025
- Q2 2025
- 8-KCI
Sep 4, 2025
- 8-KCI
Sep 2, 2025
- 10-QCI
Jul 31, 2025
- 8-KCI
Jul 31, 2025
- 8-K/ACI
Jul 28, 2025
- Q1 2025
- 8-KCI
Jun 2, 2025
- EX-99CI
Jun 2, 2025
- 8-KCI
May 20, 2025
- 10-QCI
May 2, 2025
- 8-KCI
May 2, 2025
- 8-KCI
Apr 28, 2025
- 8-KCI
Apr 18, 2025
- Q4 2024
- 8-KCI
Mar 19, 2025
- 8-KCI
Mar 13, 2025
- 8-KCI
Mar 3, 2025
- 10-KCI
Feb 27, 2025
- 8-KCI
Jan 30, 2025
- Q3 2024
- 8-KCI
Oct 31, 2024
- 10-QCI
Oct 31, 2024
- Q2 2024
- 8-KCI
Sep 3, 2024
- 8-KCI
Aug 1, 2024
- 10-QCI
Aug 1, 2024
- Q1 2024
- 8-KCI
Jun 20, 2024
- 8-KCI
Jun 6, 2024
- 8-KCI
May 2, 2024
- 10-QCI
May 2, 2024
- 8-KCI
Apr 26, 2024
- 8-KCI
Apr 26, 2024
- Q4 2023
- 8-KCI
Mar 7, 2024
- 10-KCI
Feb 29, 2024
- 8-KCI
Feb 15, 2024
- 8-KCI
Feb 13, 2024
- 8-KCI
Feb 7, 2024
- 8-KCI
Feb 2, 2024
- 8-KCI
Jan 31, 2024
- 8-KCI
Jan 22, 2024
- 8-KCI
Jan 17, 2024
- Q3 2023
- 8-KCI
Dec 29, 2023
- 8-KCI
Dec 11, 2023
- 8-KCI
Dec 4, 2023
- 8-KCI
Nov 2, 2023
- 10-QCI
Nov 2, 2023
- Q2 2023
- 8-KCI
Sep 15, 2023
- 8-KCI
Sep 11, 2023
- 10-QCI
Aug 3, 2023
Earnings releases
15 documents- Q2 2026
- EX-99CI
Sep 30, 2026
- EX-99CI
Jul 30, 2026
- Q1 2026
- EX-99CI
Apr 30, 2026
- Q4 2025
- EX-99CI
Mar 3, 2026
- EX-99CI
Feb 5, 2026
- Q3 2025
- EX-99CI
Oct 30, 2025
- Q2 2025
- EX-99CI
Jul 31, 2025
- Q1 2025
- EX-99CI
May 2, 2025
- Q4 2024
- EX-99CI
Mar 19, 2025
- EX-99CI
Jan 30, 2025
- Q3 2024
- EX-99CI
Oct 31, 2024
- Q2 2024
- EX-99CI
Aug 1, 2024
- Q1 2024
- EX-99CI
May 2, 2024
- Q4 2023
- EX-99CI
Feb 2, 2024
- Q3 2023
- EX-99CI
Nov 2, 2023
Presentations
0 documentsNo presentations for Cigna are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Cigna are held in this edition of the library.
Mentioned by
1 companyOther tracked companies whose held documents mention Cigna by name or ticker. A mention is counted once per document, from the document text the library holds.
“llars, to $1.29 billion driven substantially by growth in Asia and the acquisition of the Cigna Asian business. Life Insurance segment income was $244 million, up 102%. … …dollars. P&C net premiums earned increased 8.3%, or 9.8% in const”
See also the earnings calendar for every tracked company’s next earnings date.